Ceregene reports positive long-term follow-up results from phase I clinical trial of CERE-120 Dec. 17, 2007
Botulinum toxin type B effective in sialorrhea in amyotrophic lateral sclerosis patients Dec. 17, 2007
FDA deems Neurocrine's NDA for indiplon approvable pending additional safety and efficacy data Dec. 14, 2007
UCB reports positive results from phase III trial of Vimpat for diabetic neuropathic pain Dec. 14, 2007
RSS